These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16837641)

  • 1. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.
    Bamoulid J; Courivaud C; Deschamps M; Mercier P; Ferrand C; Penfornis A; Tiberghien P; Chalopin JM; Saas P; Ducloux D
    J Am Soc Nephrol; 2006 Aug; 17(8):2333-40. PubMed ID: 16837641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of new onset of diabetes after transplantation in stable renal recipients.
    Shehab-Eldin W; Shoker A
    Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.
    Testa R; Olivieri F; Bonfigli AR; Sirolla C; Boemi M; Marchegiani F; Marra M; Cenerelli S; Antonicelli R; Dolci A; Paolisso G; Franceschi C
    Diabetes Res Clin Pract; 2006 Mar; 71(3):299-305. PubMed ID: 16140413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
    Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study.
    Herbert A; Liu C; Karamohamed S; Liu J; Manning A; Fox CS; Meigs JB; Cupples LA
    Obesity (Silver Spring); 2006 Aug; 14(8):1454-61. PubMed ID: 16988089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
    Marso SP; House JA; Hopkins PJ
    Int J Immunogenet; 2006 Oct; 33(5):347-54. PubMed ID: 16984279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation.
    Kim YG; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim SK; Kim YH
    Transplantation; 2012 May; 93(9):900-7. PubMed ID: 22377791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity.
    Yang X; Jansson PA; Pellmé F; Laakso M; Smith U
    Obes Res; 2005 May; 13(5):813-7. PubMed ID: 15919832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of new onset diabetes after renal transplantation.
    Joss N; Staatz CE; Thomson AH; Jardine AG
    Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
    Ramesh Prasad GV; Huang M; Bandukwala F; Nash MM; Rapi L; Montada-Atin T; Meliton G; Zaltzman JS
    Clin Nephrol; 2009 Feb; 71(2):140-6. PubMed ID: 19203506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.